✦ LIBER ✦

Use of ursodeoxycholic acid in patients with liver disease

✍ Scribed by Paul Angulo

Book ID: 107537905
Publisher: Springer
Year: 2002
Tongue: English
Weight: 449 KB
Volume: 4
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-002-0036-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic Acid Suppresses Extent o

Ursodeoxycholic Acid Suppresses Extent of Lipid Peroxidation in Diseased Liver in Experimental Cholestatic Liver Disease

✍ Predrag Ljubuncic; Zahava Tanne; Arieh Bomzon 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 89 KB

Use of statins in patients with liver di

Use of statins in patients with liver disease

✍ Sweta Tandra; Raj Vuppalanchi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 234 KB

Disposition of valproic acid in patients

Disposition of valproic acid in patients with liver disease

✍ U. Klotz; T. Rapp; W. A. Müller 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 670 KB

Jeune syndrome and liver disease: Report

Jeune syndrome and liver disease: Report of three cases treated with ursodeoxycholic acid

✍ Labrune, Philippe; Fabre, Monique; Trioche, Pascale; Estournet-Mathiaud, Brigitt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

Three children with Jeune syndrome (asphyxiating thoracic dystrophy) had clinical and laboratory evidence of liver disease. In two patients the disease evolved to biliary cirrhosis, whereas in the third it was recognized when extensive fibrosis was developing. In the three patients, treatment with u

Endogenous ursodeoxycholic acid and chol

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis

✍ Jeffery L. Smith; Peter J. Lewindon; Anita C. Hoskins; Tamara N. Pereira; Kennet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Focal biliary cirrhosis causes significant morbidity and mortality in cystic fibrosis (CF). Although the mechanisms of pathogenesis remain unclear, bile acids have been proposed as potential mediators of liver injury. This study examined bile acid composition in CF and assessed altered bile acid pro

Ursodeoxycholic acid for liver disease a

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial

✍ C Colombo; P M Battezzati; M Podda; N Bettinardi; A Giunta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

AND THE ITALIAN GROUP FOR THE STUDY OF URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS\* ment. Thus, we concluded that UDCA administration im-Liver disease is increasingly recognized as a major proves clinical and biochemical parameters in CF pacause of morbidity in cystic fibrosis (CF). Preliminary tients